The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
The DOI matches its Crossref record; 250 of the 251 references it cites were found in a registry or an index.
Abstract
Newer generation antidepressant drugs (ADs) are widely used as the first line of treatment for major depressive disorders and are considered to be safer than tricyclic agents. In this critical review, we evaluated the literature on adverse events, tolerability and safety of selective serotonin reuptake inhibitors, serotonin noradrenaline reuptake inhibitors, bupropion, mirtazapine, trazodone, agomelatine, vilazodone, levomilnacipran and vortioxetine. Several side effects are transient and may disappear after a few weeks following treatment initiation, but potentially serious adverse events may persist or ensue later. They encompass gastrointestinal symptoms (nausea, diarrhea, gastric bleeding, dyspepsia), hepatotoxicity, weight gain and metabolic abnormalities, cardiovascular disturbances (heart rate, QT interval prolongation, hypertension, orthostatic hypotension), genitourinary symptoms (urinary retention, incontinence), sexual dysfunction, hyponatremia, osteoporosis and risk of fractures, bleeding, central nervous system disturbances (lowering of seizure threshold, extrapyramidal side effects, cognitive disturbances), sweating, sleep disturbances, affective disturbances (apathy, switches, paradoxical effects), ophthalmic manifestations (glaucoma, cataract) and hyperprolactinemia. At times, such adverse events may persist after drug discontinuation, yielding iatrogenic comorbidity. Other areas of concern involve suicidality, safety in overdose, discontinuation syndromes, risks during pregnancy and breast feeding, as well as risk of malignancies. Thus, the rational selection of ADs should consider the potential benefits and risks, likelihood of responsiveness to the treatment option and vulnerability to adverse events. The findings of this review should alert the physician to carefully review the appropriateness of AD prescription on an individual basis and to consider alternative treatments if available.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Common side effects include nausea, vomiting, diarrhea, headache, insomnia, and agitation (104).”
From The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease (2023) · cites this paper as [104]
In the citing paper
“Another drawback of long-term antidepressant treatment is concerned with the serious and bothersome side effects that may ensue with SSRI and SNRI, such as high rates of sexual dysfunction, bleeding (in particular gastrointestinal), weight gain, risk of fracture and osteoporosis, and hyponatremia.73”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [73]
In the citing paper
“Examples are switching from unipolar to bipolar course with antidepressant drugs [6,31] and supersensitivity psychosis, the onset of psychotic symptoms and co-occurring movement disorder with antipsychotic medications [4].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
In the citing paper
“For instance, several side effects of antidepressants are transient and may disappear after a few weeks following treatment initiation, but potentially serious adverse events may persist or ensue later.”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
In the citing paper
“Since gastric symptomatology did not follow the somatic patterns typical of anxiety disturbances, venlafaxine was also suspected as a iatrogenic cause [6].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Barbui, C., Hotopf, M., Freemantle, N., Boynton, J., Churchill, R., Eccles, M., Geddes, Jr., Hardy, R., Lewis, G., & Mason, J. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002791 · Cited by 86
RetractedProjections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Suicide and suicidal behaviour
Turecki, G., & Brent, D. A. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00234-2 · Cited by 2,338
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Prevalence of Depression During Pregnancy: Systematic Review
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000116689.75396.5f · Cited by 1,725
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Apathy and the Functional Anatomy of the Prefrontal Cortex–Basal Ganglia Circuits
Levy, R., & Dubois, B. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj043 · Cited by 1,285
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Kessler, R. C. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.11.005 · Cited by 871
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833
Research works printed but not linked: 2
- 10.1345/aph.1A254 · doi:10.1345/aph.1a254 · Paper page
- 10.1210/endo.133.2.8344205 · doi:10.1210/endo.133.2.8344205 · Paper page
Cited by
Items 201–300 of 654
Shin, C., Jeon, S. W., Lee, S., Pae, C., Hong, N., Lim, H. K., Patkar, A. A., Masand, P. S., An, H., & Han, C. (2023) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2023.21.1.135 · Cited by 22
Holper, L. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.11.012 · Cited by 22
Sun, Y., Ji, M., Zhang, X., Chen, J., Wang, Y., & Wang, Z. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.06.017 · Cited by 19
Jacobsen, P. L., Thorley, E. M., & Curran, C. (2020) · Neurology, Psychiatry and Brain Research · doi:10.1016/j.npbr.2020.03.002 · Cited by 19
Singh, N., Hazari, P. P., Mittal, P., Yadav, S. K., Kumar, N., Mishra, G., Dahiya, S., & Mishra, A. K. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177737 · Cited by 24
Fang, Y., Fritsche, L. G., Mukherjee, B., Sen, S., & Richmond‐Rakerd, L. S. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.06.004 · Cited by 22
Therapeutic Implications of microRNAs in Depressive Disorders: A Review
Hassan, M., Amir, A., Shahzadi, S., & Kloczkowski, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113530 · Cited by 24
Illuminating the way: the role of bright light therapy in the treatment of depression
Rajačić, B. K., Šagud, M., Pivac, N., & Begić, D. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2273396 · Cited by 20
Research progress on antidepressant effects and mechanisms of berberine
Gao, Y., Nie, K., Wang, H., Dong, H., & Tang, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1331440 · Cited by 25
Antidepressant-Induced Acute Liver Injury: A Case–Control Study in an Italian Inpatient Population
on behalf of DILI-IT Study Group, Ferrajolo, C., Scavone, C., Donati, M., Bortolami, O., Stoppa, G., Motola, D., Vannacci, A., Mugelli, A., Leone, R., et al. (2017) · Drug Safety · doi:10.1007/s40264-017-0583-5 · Cited by 19
Redox metabolism modulation as a mechanism in SSRI toxicity and pharmacological effects
Ștefan, M.-G., Kiss, B., Gutleb, A. C., & Loghin, F. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02721-6 · Cited by 22
Cellular Response to Unfolded Proteins in Depression
Kowalczyk, M., Kowalczyk, E., Kwiatkowski, P. A., Łopusiewicz, Ł., Talarowska, M. E., & Sienkiewicz, M. (2021) · Life · doi:10.3390/life11121376 · Cited by 22
Saiz‐Rodríguez, M., Belmonte, C., Derqui, N., Cabaleiro, T., Román, M. C., Ochoa, D., Talegón, M., Ovejero-Benito, M. C., & Abad‐Santos, F. (2017) · Pharmacogenomics · doi:10.2217/pgs-2017-0116 · Cited by 19
Prescribing Pharmacotherapy for Major Depressive Disorder: How Does a Clinician Decide?
Cosci, F., & Fava, G. A. (2021) · Biomedicine Hub · doi:10.1159/000519656 · Cited by 19
Self-citationMarcinkowska, M., Bucki, A., Śniecikowska, J., Zagórska, A., Fajkis-Zajączkowska, N., Siwek, A., Głuch‐Lutwin, M., Żmudzki, P., Jastrzębska‐Więsek, M., Partyka, A., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00497 · Cited by 20
Ekhart, C., van Hunsel, F. P. A. M., van Puijenbroek, E., Chandler, R. E., Meldau, E.-L., Taavola, H., & Norén, G. N. (2022) · Drug Safety · doi:10.1007/s40264-021-01139-y · Cited by 18
Cutting the First Turf to Heal Post-SSRI Sexual Dysfunction: A Male Retrospective Cohort Study
Luca, R. D., Bonanno, M., Manuli, A., & Calabrò, R. S. (2022) · Medicines · doi:10.3390/medicines9090045 · Cited by 19
Ulusoy, H. İ., Polat, Ü., & Ulusoy, S. (2023) · RSC Advances · doi:10.1039/d3ra02442c · Cited by 18
Treating depression in clinical practice: new insights on the multidisciplinary use of trazodone
Albert, U., Tomasetti, C., Marra, C., Neviani, F., Pirani, A., Taddeo, D., Zanetti, O. O., & Maina, G. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1207621 · Cited by 20
Cheng, A. L., Anderson, J., Didehbani, N., Fine, J. S., Fleming, T. K., Karnik, R., Longo, M. T., Ng, R., Re’em, Y., Sampsel, S., et al. (2023) · PM&R · doi:10.1002/pmrj.13085 · Cited by 23
Lipone, P., Ehler, E., Nastaj, M., Palka-Kisielowska, I., Cruccu, G., Truini, A., Loreto, G. D., Vecchio, A. D., Pochiero, I., Comandini, A., et al. (2020) · CNS Drugs · doi:10.1007/s40263-020-00760-2 · Cited by 19
Tafseer, S., Gupta, R., Ahmad, R. S., Jain, S., Bhatia, M. S., & Gupta, L. K. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173073 · Cited by 19
Yang, Y. K., Chen, C., Tsai, C.-F., Chang, C., Lai, T.-J., Lee, C.-T., Lin, C., Lan, T., & Herr, K. J. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1980869 · Cited by 19
Aberrant Tryptophan Metabolism Manipulates Osteochondral Homeostasis
Xiang, T., Yang, C., Xie, L., Xiao, S., Tang, Y., Huang, G., Sun, D., Chen, Y., & Luo, F. (2025) · Research · doi:10.34133/research.0728 · Cited by 17
Yao, L., Jing, R., Wang, C.-C., Wang, Y., Li, X., Wu, X. M., Wang, Y., Liu, L., Mu, L.-H., Liu, P., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120011 · Cited by 18
Ortuño, M. J., Schneeberger, M., Ilanges, A., Marchildon, F., Pellegrino, K., Friedman, J. M., & Ducy, P. (2021) · Journal of Clinical Investigation · doi:10.1172/jci151976 · Cited by 19
From gut to brain: understanding the role of microbiota in inflammatory bowel disease
Wang, S., Zhou, S., Han, Z., Yu, B., Xu, Y., Lin, Y., Chen, Y., Jin, Z., Li, Y., Cao, Q., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1384270 · Cited by 22
Maggo, S. D. S., Kennedy, M. A., Barczyk, Z. A., Miller, A. L., Rucklidge, J. J., Mulder, R., & Foulds, J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01199 · Cited by 24
The Effectiveness of Cannabis Flower for Immediate Relief from Symptoms of Depression.
Li, X., Diviant, J. P., Stith, S. S., Brockelman, F., Keeling, K., Hall, B., & Vigil, J. M. (2020) · The Yale Journal of Biology and Medicine · Cited by 38
Hu, Y., Wang, Y., Chen, C., Yang, W., Zhu, W., Wang, Y., & Liu, P. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114549 · Cited by 20
Rask, O., Nordenskjöld, A., Johansson, B. A., & Movahed, P. (2022) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-022-02123-2 · Cited by 18
Cosci, F., Svicher, A., Romanazzo, S., Maggini, L., Cesaris, F. D., Benemei, S., & Geppetti, P. (2019) · CNS Spectrums · doi:10.1017/s1092852919001536 · Cited by 19
An Updated List of Neuromedicinal Plants of Pakistan, Their Uses, and Phytochemistry
Khan, A. W., Khan, A., Shah, S. M. M., Ullah, A., Faheem, M., & Saleem, M. H. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/6191505 · Cited by 18
Gao, N., Zheng, W., Tiliwaerde, M., Gu, W., Li, X., & Jin, Z. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13630 · Cited by 16
Zhao, X., Karkare, S. U., Nash, A. I., Sheehan, J. J., Aboumrad, M., Near, A. M., Banerji, T., & Joshi, K. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.03.058 · Cited by 17
Liu, J., Li, R., Zhang, T., Xue, R., Li, T., Li, Z., Zhuang, X., Wang, Q., Chen, Y.-A., Dong, J., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05042-x · Cited by 17
García–Villanueva, C., Millá, E., Bolarín, J. M., García‐Medina, J. J., Cruz-Espinosa, J., Sánchez, J. B. D. C., Salgado-Borges, J. M., Hernández-Martínez, F. J., Bendala-Tufanisco, E., Andrés‐Blasco, I., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195649 · Cited by 20
Wróbel, A., Serefko, A., Woźniak, A., Kociszewski, J., Szopa, A., Wiśniewski, R., & Poleszak, E. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172842 · Cited by 17
Goerigk, S. A., Padberg, F., Chekroud, A. M., Kambeitz, J. P., Bühner, M., & Brunoni, A. R. (2021) · Brain stimulation · doi:10.1016/j.brs.2021.05.008 · Cited by 20
Self-citationRuffini, G., Salvador, R., Castaldo, F., Baleeiro, T., Camprodon, J. A., Chopra, M. P., Cappon, D., & Pascual‐Leone, Á. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1427365 · Cited by 20
Chen, Y., Tong, S., Xu, Y., Xu, Y., Wu, Z., Zhu, X., Wang, X., Li, C., Lin, C., Li, X., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70035 · Cited by 18
“Novel Psychopharmacology for Depressive Disorders”
Fornaro, M., Berardis, D. D., Anastasia, A., & Fusco, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_22 · Cited by 16
Yu, W. S., Kwon, S., Agadagba, S. K., Chan, L.-L.-H., Wong, K.-H., & Lim, L. W. (2021) · Cells · doi:10.3390/cells10092492 · Cited by 18
Combs, D., Edgin, J. O., Hsu, C., Bottrill, K., Vorce, H. V., Gerken, B., Matloff, D. S., Rue, S. L., & Parthasarathy, S. (2023) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10764 · Cited by 16
Disrupting the Mood and Obesity Cycle: The Potential Role of Metformin
Doan, S. N., Patel, S. K., Xie, B., Nelson, R. A., & Yee, L. D. (2023) · Obesities · doi:10.3390/obesities3010006 · Cited by 17
Cao, Z., Min, J., Xiang, Y., Wang, X., & Xu, C. (2024) · BMJ Mental Health · doi:10.1136/bmjment-2023-300915 · Cited by 17
Antidepressant-induced membrane trafficking regulates blood-brain barrier permeability
Du, W., Chen, H., Gróf, I., Lemaitre, L., Bocsik, A., Perdyan, A., Mieczkowski, J., Deli, M. A., Hortobágyi, T., Wan, Q., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02626-1 · Cited by 15
Asmar, K. E., Fève, B., Colle, R., Trabado, S., Verstuyft, C., Gressier, F., Vievard, A., Haffen, É., Polosan, M., Ferreri, F., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.10.021 · Cited by 15
Withdrawal Symptoms Following Discontinuation of Vortioxetine—Retrospective Chart Review
Siwek, M., Chrobak, A. A., Gorostowicz, A., Krupa, A. J., & Dudek, D. (2021) · Pharmaceuticals · doi:10.3390/ph14050451 · Cited by 15
Ishtiak‐Ahmed, K., Köhler‐Forsberg, O., Mortensen, E. L., Nierenberg, A. A., & Gasse, C. (2023) · Drugs & Aging · doi:10.1007/s40266-023-01018-4 · Cited by 17
Effects of novel antidepressant drugs on mesenchymal stem cell physiology
Ferroni, L., Gardin, C., Bellin, G., Vindigni, V., Pavan, C., & Zavan, B. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108853 · Cited by 14
Borrione, L., Suen, P. J. C., Razza, L. B., dos Santos, L. A., Sudbrack-Oliveira, P., & Brunoni, A. R. (2020) · Expert Review of Medical Devices · doi:10.1080/17434440.2020.1813565 · Cited by 15
Self-citationAi, Z., Yuan, D., Meng, Y., Ai, Z., & Zhu, S. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1188341 · Cited by 19
Cuomo, A., Aguglia, A., Berardis, D. D., Ventriglio, A., Gesi, C., & Fagiolini, A. M. (2024) · Annals of General Psychiatry · doi:10.1186/s12991-024-00505-1 · Cited by 13
Neuroleptic malignant syndrome and serotonin syndrome: a comparative bibliometric analysis
Sweileh, W. M. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03227-5 · Cited by 14
Wang, Y., Chen, L., Zhong, X.-L., Liu, Q., Li, W., Cheng, Y., & Du, Y. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03378-4 · Cited by 15
Hirano, Y. (2020) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-019-00026-0 · Cited by 14
Antidepressants: Indications, Contraindications, Interactions, and Side Effects
Corponi, F., Fabbri, C., & Serretti, A. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_29-1 · Cited by 15
Li, H.-H., Yao, X.-Y., Tao, S., Sun, X., Li, P.-P., Li, X.-X., Liu, Z.-L., & Ren, C. (2021) · Behavioural Neurology · doi:10.1155/2021/5533827 · Cited by 13
DelRosso, L. M., Mogavero, M. P., Fickensher, A., Bruni, O., Schenck, C. H., & Ferri, R. (2022) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10282 · Cited by 15
de Azevedo, H. F. Z., Ferreira, M. A., Costa, R. W., Russo, V., Russo, E., Mascarello, A., & Guimarães, C. R. W. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109707 · Cited by 14
Neuropsychiatric aspects of Parkinson disease psychopharmacology: Insights from circuit dynamics
Butala, A., Shepard, M. D., & Pontone, G. M. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64012-3.00007-1 · Cited by 15
Holper, L., & Hengartner, M. P. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02839-y · Cited by 16
Aakjær, M., Bruin, M. L. D., Külahçı, M., & Andersen, M. T. (2021) · Drug Safety · doi:10.1007/s40264-021-01110-x · Cited by 13
Treatment-resistant depression reconsidered
Schroder, H. S., Patterson, E. H., & Hirshbein, L. (2022) · SSM - Mental Health · doi:10.1016/j.ssmmh.2022.100081 · Cited by 18
Plaeke, P., Eede, F. V. D., Gys, B., Beunis, A., Ruppert, M., Man, J. D., Winter, B. Y. D., & Hubens, G. (2019) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-019-01784-z · Cited by 13
Depression in the Medically Ill: An Integrated Approach
Rodin, G., Craven, J., & Littlefield, C. H. (2017) · Routledge eBooks · doi:10.4324/9781315094991 · Cited by 14
Tao, L., Gao, J., Feng, R., Zheng, Y., Tian, K., Chen, J., & Xu, X. (2024) · Processes · doi:10.3390/pr12071372 · Cited by 12
Gao, K., & Calabrese, J. R. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.07.016 · Cited by 14
Gastrointestinal adverse events associated with SNRIs: A FAERS-based pharmacovigilance study
Lin, J., Wei, S., Peng, Y., Liang, C., Jiao, W., Ji, Y., Deng, Y., Yan, F., & Xi, J. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119484 · Cited by 12
Adjunctive antidepressants in bipolar depression
Vieta, E., & Garriga, M. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30347-9 · Cited by 12
Self-citationKelly, D. L., Claxton, A., Bidollari, I., & Du, Y. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.114030 · Cited by 15
Siraj, R. A., Bolton, C. E., & McKeever, T. M. (2023) · Thorax · doi:10.1136/thorax-2022-219736 · Cited by 13
Antidepressants and Incident Hypertension in Primary Care Patients
Breeden, M. A., Brieler, J. A., Salas, J., & Scherrer, J. F. (2018) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2018.01.170234 · Cited by 13
Zhao, Y., Chen, J., Liu, Q., & Li, Y. (2020) · Molecules · doi:10.3390/molecules25020406 · Cited by 12
Bursky, M., Egglefield, D. A., Schiff, S., Premnath, P. Y., & Sneed, J. R. (2022) · Brain Sciences · doi:10.3390/brainsci12050663 · Cited by 16
Antidepressant Discontinuation Syndrome
Kim, S. H., Kim, Y. S., & Kang, U. G. (2024) · 신경정신의학 · doi:10.4306/jknpa.2024.63.2.104 · Cited by 12
What psychologists need to know about psychotropic medications
Tomba, E., Guidi, J., & Fava, G. A. (2018) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2154 · Cited by 11
Self-citationJiang, A., Wei, C., Zhu, W., Wu, F., & Wu, B. (2024) · Therapeutic Advances in Drug Safety · doi:10.1177/20420986241244585 · Cited by 15
Efthimiou, A. A., Cardinale, A. M., & Kepa, A. (2024) · Psychedelic Medicine · doi:10.1089/psymed.2023.0058 · Cited by 11
Rigdon, G. C., Prescott, Y., Hall, J. P., Abernathy, K., Raskin, J., & Wargin, W. A. (2024) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.1488 · Cited by 12
The “pharmaceuticalisation” of life
Braillon, A., Lexchin, J., Blumsohn, A., & Hengartner, M. P. (2019) · BMJ · doi:10.1136/bmj.l1972 · Cited by 11
Peng, C., Wang, L., Xu, L., Zhou, Y., Zhao, G., Zhang, L. R., & Li, W. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.892133 · Cited by 12
Partyka, A., Zagórska, A., Kotańska, M., Walczak, M., Jastrzębska‐Więsek, M., Knutelska, J., Bednarski, M., Głuch‐Lutwin, M., Mordyl, B., Janiszewska, P., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237196 · Cited by 11
Development of a carbon-11 PET radiotracer for imaging TRPC5 in the brain
Yu, Y., Liang, Q., Liu, H., Luo, Z., Hu, H., Perlmutter, J. S., & Tu, Z. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob00893d · Cited by 11
Jennings, L. (2018) · Springer eBooks · doi:10.1007/978-3-319-74604-3_4 · Cited by 14
Sertraline in primary care: comments on the PANDA trial
Hengartner, M. P., Plöderl, M., Braillon, A., Jakobsen, J. C., & Gluud, C. N. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30381-5 · Cited by 11
Patacchini, A., & Cosci, F. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001154 · Cited by 10
Zhou, Y.-M., Yuan, J.-J., Xu, Y.-Q., Gou, Y.-H., Zhu, Y. Y. X., Chen, C., Huang, X., Ma, X., Pi, M., & Yang, Z. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1228940 · Cited by 11
Kwon, T.-G., Kim, Y. J., Hong, J.-Y., Song, J.-H., & Park, J.-Y. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155387 · Cited by 11
From Efficacy to Adversity: Understanding the Side Effects of Antidepressants - systematic review
Hrabar, V., Studeniak, T., Pryima, M., & Kondratskyi, V. (2025) · Wiadomości Lekarskie · doi:10.36740/wlek/197143 · Cited by 11
Zhu, Y., Li, Y., Yu, Z., Chen, X., Lan, T., Wang, M., & Yu, S. Y. (2025) · Antioxidants · doi:10.3390/antiox14040410 · Cited by 12
Public psychology and holistic approaches to prevention and treatment of depression
Patterson, E. H., Miller, C., & Hannapel, M. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1600094 · Cited by 13
Patacchini, A., & Cosci, F. (2021) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-200074 · Cited by 12
Elsayed, M., Mohamed, K. A., Dardeer, K. T., Zaafar, D. K., Hassanin, S. O., Abdelnaby, R., & Schönfeldt‐Lecuona, C. (2021) · Trends in Psychiatry and Psychotherapy · doi:10.47626/2237-6089-2021-0338 · Cited by 10
Moon, S. W., Kim, J. W., Kim, D. H., Lee, K. Y., Reines, E. H., Lee, M., & Park, Y. J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1075939 · Cited by 12
Mușat, M. I., Militaru, F., Gheorman, V., Udriștoiu, I., Mitran, S. I., & Cătălin, B. (2024) · Diagnostics · doi:10.3390/diagnostics14111140 · Cited by 13
Complementary health approaches for postpartum depression: A systematic review
McCloskey, R. J., & Reno, R. (2018) · Social Work in Mental Health · doi:10.1080/15332985.2018.1509412 · Cited by 14
Naves, M. P. C., de Morais, C. R., Spanó, M. A., & de Rezende, A. A. A. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.06.004 · Cited by 10
Benzodiazepines’ Role in Managing Gastrointestinal Disorders
Balon, R., Sonino, N., & Rafanelli, C. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000510686 · Cited by 10
Metadata
- Authors
- Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Universidade de São Paulo (BR)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- University at Buffalo, State University of New York (US)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 85
- Issue
- 5
- Pages
- 270-288
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2477696699
- Semantic Scholar
- 4af046d5cf1f48ed09514ffef416d2de5c0d29cf
- Cited by
- 650
- References
- 251
- Citations by year
- 2026: 46 · 2025: 67 · 2024: 95 · 2023: 84 · 2022: 81 · 2021: 75 · 2020: 55 · 2019: 54 · 2018: 50 · 2017: 38 · 2016: 4
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- newer antidepressants, antidepressant side effects, drug safety, tolerability, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, bupropion, mirtazapine, trazodone, agomelatine, vilazodone, levomilnacipran, vortioxetine, gastrointestinal adverse effects, hepatotoxicity, weight gain, QT prolongation, sexual dysfunction, hyponatremia, osteoporosis, paradoxical effects, suicidality, antidepressant overdose, discontinuation syndrome, pregnancy and lactation, cancer risk, drug selection
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Humans, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.